X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2053) 2053
Publication (199) 199
Book Review (39) 39
Book Chapter (20) 20
Book / eBook (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1192) 1192
index medicus (1084) 1084
animals (683) 683
oncology (621) 621
cancer (576) 576
antitumor-activity (464) 464
antineoplastic agents - pharmacology (399) 399
cell line, tumor (390) 390
selective inhibitor (387) 387
pharmacology & pharmacy (379) 379
chemistry, medicinal (357) 357
biochemistry & molecular biology (331) 331
apoptosis (322) 322
mice (321) 321
female (303) 303
analysis (210) 210
in-vitro (207) 207
structure-activity relationship (202) 202
antineoplastic agents - chemistry (200) 200
care and treatment (198) 198
antineoplastic agents - therapeutic use (193) 193
selective-inhibition (191) 191
cell proliferation - drug effects (190) 190
neoplasms - drug therapy (188) 188
male (178) 178
research (178) 178
proteins (175) 175
chemistry, organic (170) 170
health aspects (167) 167
selective inhibitors (167) 167
cell biology (165) 165
apoptosis - drug effects (163) 163
tumors (157) 157
in-vivo (155) 155
article (153) 153
expression (146) 146
chemotherapy (141) 141
dose-response relationship, drug (140) 140
chemistry, multidisciplinary (131) 131
drug design (127) 127
protein kinase inhibitors - pharmacology (121) 121
mice, nude (120) 120
molecular structure (118) 118
selective antitumor-activity (117) 117
breast cancer (116) 116
antineoplastic agents - chemical synthesis (115) 115
biological evaluation (112) 112
cell cycle (111) 111
potent (111) 111
cells (107) 107
xenograft model antitumor assays (106) 106
drug discovery (99) 99
kinases (98) 98
antitumor activity (97) 97
cytotoxicity (97) 97
medicine, research & experimental (97) 97
tumor cells, cultured (97) 97
gene expression (96) 96
growth (96) 96
antineoplastic agents (93) 93
drug screening assays, antitumor (93) 93
review (93) 93
signal transduction (93) 93
signal transduction - drug effects (92) 92
breast-cancer (91) 91
derivatives (91) 91
medicine (91) 91
antimitotic agents (90) 90
clinical trials (90) 90
cancer therapies (86) 86
phase-i (86) 86
inhibitors (85) 85
metastasis (85) 85
activation (84) 84
cell survival - drug effects (83) 83
chemistry (83) 83
phosphorylation (83) 83
therapy (83) 83
hematology (82) 82
neoplasms - pathology (81) 81
research article (81) 81
genetic aspects (80) 80
mutation (80) 80
immunology (79) 79
neoplasms - metabolism (79) 79
pharmacology (79) 79
multidisciplinary sciences (77) 77
design (76) 76
enzyme inhibitors - pharmacology (76) 76
middle aged (76) 76
models, molecular (76) 76
inhibition (75) 75
cancer-cells (74) 74
drug therapy (74) 74
breast neoplasms - drug therapy (73) 73
clinical trials as topic (73) 73
medicine & public health (72) 72
antineoplastic agents - administration & dosage (71) 71
protein kinase inhibitors - therapeutic use (70) 70
anticancer properties (69) 69
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2059) 2059
Chinese (8) 8
German (3) 3
Japanese (3) 3
French (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2008, Volume 7, Issue 7, pp. 1851 - 1863
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2015, Volume 14, Issue 7, pp. 1570 - 1581
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 09/2015, Volume 26, Issue 9, pp. 948 - 956
Journal Article
Molecular Therapy, ISSN 1525-0016, 01/2015, Volume 23, Issue 1, pp. 202 - 214
Journal Article
Journal Article
Journal Article
by Wang, F and Zheng, L and Yi, YY and Yang, Z and Qiu, Q and Wang, XY and Yan, W and Bai, P and Yang, JH and Li, D and Pei, HY and Niu, T and Ye, HY and Nie, CL and Hu, YG and Yang, SY and Wei, YQ and Chen, LJ
MOLECULAR CANCER THERAPEUTICS, ISSN 1535-7163, 04/2018, Volume 17, Issue 4, pp. 763 - 775
Our previous study reported that SKLB-23bb, an orally bioavailable HDAC6-selective inhibitor, exhibited superior antitumor efficiency both in vitro and in vivo... 
MULTIPLE-MYELOMA | ANTICANCER ACTIVITY | SELECTIVE HDAC6 INHIBITOR | IN-VITRO | ONCOLOGY | PROTEASOME | RICOLINOSTAT | HISTONE DEACETYLASE 6 | TUBULIN | CANCER | SMALL-MOLECULE INHIBITOR
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4793 - 4804
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2017, Volume 131, Issue 1, pp. 41 - 48
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 9749 - 11
Journal Article
Coordination Chemistry Reviews, ISSN 0010-8545, 2002, Volume 232, Issue 1, pp. 127 - 135
Well known for their clinical anti-arthritic properties, gold-based drugs have also attracted interest as potential antitumor agents with gold(I) phosphine... 
Cytotoxicity | Mitochondria | Antitumor agents | Gold(I) phosphines | Selective toxicity | Mode of action | HEPATOCYTES | mode of action | mitochondria | INVITRO | COMPOUND | selective toxicity | TOXICITY | antitumor agents | CHEMISTRY, INORGANIC & NUCLEAR | gold(I) phosphines | THERAPY | COORDINATION-COMPLEXES | AURANOFIN | TARGETS | CELL | cytotoxicity | CHLORIDE
Journal Article